Patent · US Active

Solid state forms of a quinazoline derivative and its use as a BRAF inhibitor

US9987281B2 · kind B2 · utility

0Cited by

5References

20Claims

0Family size

Assignee

Ignyta, Inc. · US

Inventors

Stephen Bierlmaier · Towanda, US
Ralph C. Haltiwanger · West Chester, US
Martin J. Jacobs · West Chester, US

Key dates

Filing date	Jun 23, 2017
Grant date	Jun 5, 2018
Priority date	—
Expiry date	Jun 23, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This application relates to various salts and solid state forms of Compound (I). This application also relates to pharmaceutical compositions and therapeutic uses of these materials and compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.